Literature DB >> 19728133

Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease.

Rajinder Singh1, Prem C Verma, Satparkash Singh.   

Abstract

Virosome based vaccines against Newcastle disease (ND) were prepared and evaluated for their immunogenicity and protective efficacy in chickens. Envelop of Newcastle disease virus (NDV) was solubilised with Triton X-100 to yield virosomes which were later on encapsulated in poly-lactide-co-glycolide (PLG) microspheres. The birds were immunized intranasally with virosomes or PLG microspheres encapsulated virosomes, and efficacy of these preparations was compared with commercial LaSota vaccine. The preparations protected the chickens against virulent virus challenge infection, however the microencapsulated virosome vaccine gave slightly lesser degree of protection than non encapsulated counterpart. The humoral and cell mediated immune response generated as well as the protection afforded by virosome preparations were found to be comparable with LaSota vaccine. The results substantiate the potential of virosome based vaccines to provide high level of immunity and protection against Newcastle disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728133     DOI: 10.1007/s11250-009-9444-2

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  35 in total

1.  Mucosal antibody response induced with a nasal virosome-based influenza vaccine.

Authors:  P Durrer; U Glück; C Spyr; A B Lang; R Zurbriggen; C Herzog; R Glück
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

2.  Presence of viral antigens and antibody in the trachea of chickens infected with avian infectious bronchitis virus.

Authors:  R A Hawkes; J H Darbyshire; R W Peters; A P Mockett; D Cavanagh
Journal:  Avian Pathol       Date:  1983       Impact factor: 3.378

3.  Investigation of problems associated with intramuscular breast injection of oil-adjuvanted killed vaccines in chickens.

Authors:  R Droual; A A Bickford; B R Charlton; D R Kuney
Journal:  Avian Dis       Date:  1990 Apr-Jun       Impact factor: 1.577

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes).

Authors:  R Bron; A Ortiz; J Dijkstra; T Stegmann; J Wilschut
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.

Authors:  J E Rosas; R M Hernández; A R Gascón; M Igartua; F Guzman; M E Patarroyo; J L Pedraz
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

7.  Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.

Authors:  R Ramya; P C Verma; V K Chaturvedi; P K Gupta; K D Pandey; M Madhanmohan; T R Kannaki; R Sridevi; B Anukumar
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

8.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; T R Tice; R M Gilley
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes.

Authors:  Cornelia Speth; Simon Bredl; Magdalena Hagleitner; Jens Wild; Manfred Dierich; Hans Wolf; Josef Schroeder; Ralf Wagner; Ludwig Deml
Journal:  Virology       Date:  2008-10-21       Impact factor: 3.616

10.  Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.

Authors:  Mangala Rao; Mike Bray; Carl R Alving; Peter Jahrling; Gary R Matyas
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  2 in total

1.  Development, Biological Characterization, and Immunological Evaluation of Virosome Vaccine against Newcastle Disease in Pakistan.

Authors:  Muhammad Hidayat Rasool; Asif Mehmood; Muhammad Saqalein; Muhammad Atif Nisar; Ahmad Almatroudi; Mohsin Khurshid
Journal:  Biomed Res Int       Date:  2021-01-29       Impact factor: 3.411

2.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.